Fate Therapeutics, Inc. (FATE)

Oncology Corporate Profile

Stock Performance

3.9000
-0.2200

3 Month Stock History Chart

HQ Location

3535 General Atomics Court, Ste 200
San Diego, CA 92121

Company Description

Fate Therapeutics is a clinical-stage biopharmaceutical company engaged in the discovery and development of pharmacologic modulators of adult stem cells to treat orphan diseases, including certain hematologic malignancies, lysosomal storage disorders and muscular dystrophies. The Company utilizes established pharmacologic modalities, including small molecules and therapeutic proteins, and well-characterized biological mechanisms to enhance the therapeutic potential of adult stem cells.

Website: http://www.fatetherapeutics.com

This company does not have any commercial products
  • Brand
  • Generic
  • Investigational
Brand / Product Class Area of Study Phase Partnership
prohemastem cell therapeuticVarious cancer typesII

View additional information on product candidates here »

Source: http://www.fatetherapeutics.com

Recent News Headlines

8/21/2017 06:19 am

8/21/2017 06:19 am

8/21/2017 06:19 am

8/16/2017 06:18 am

8/16/2017 06:18 am

8/16/2017 06:18 am

8/15/2017 06:18 am

8/15/2017 06:18 am

8/14/2017 12:18 pm

8/14/2017 12:18 pm

8/14/2017 06:18 am

8/12/2017 06:18 am

8/9/2017 06:18 am

8/8/2017 06:18 am

8/7/2017 06:18 am

8/6/2017 12:21 pm

7/13/2017 12:18 pm

6/14/2017 12:18 pm

6/10/2017 12:18 pm

6/7/2017 12:18 pm

5/29/2017 06:17 pm

5/28/2017 12:17 am

5/25/2017 06:17 am

5/24/2017 06:17 am

5/24/2017 06:17 am